GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » Cash-to-Debt

Omnimmune Holdings (Omnimmune Holdings) Cash-to-Debt : 0.00 (As of Sep. 2010)


View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Omnimmune Holdings's cash to debt ratio for the quarter that ended in Sep. 2010 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Omnimmune Holdings couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2010.

The historical rank and industry rank for Omnimmune Holdings's Cash-to-Debt or its related term are showing as below:

OMMH's Cash-to-Debt is not ranked *
in the Biotechnology industry.
Industry Median: 6.49
* Ranked among companies with meaningful Cash-to-Debt only.

Omnimmune Holdings Cash-to-Debt Historical Data

The historical data trend for Omnimmune Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Omnimmune Holdings Cash-to-Debt Chart

Omnimmune Holdings Annual Data
Trend May07 May08 Dec09
Cash-to-Debt
No Debt - -

Omnimmune Holdings Quarterly Data
May07 Aug07 Nov07 Feb08 May08 Aug08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.04 -

Competitive Comparison of Omnimmune Holdings's Cash-to-Debt

For the Biotechnology subindustry, Omnimmune Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnimmune Holdings's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omnimmune Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Omnimmune Holdings's Cash-to-Debt falls into.



Omnimmune Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Omnimmune Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2009 is calculated as:

Omnimmune Holdings's Cash to Debt Ratio for the quarter that ended in Sep. 2010 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnimmune Holdings  (GREY:OMMH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Omnimmune Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnimmune Holdings (Omnimmune Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027
Website
Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines